I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Tislelizumab plus chemotherapy versus placebo plus chemothe..:
Xu, Jianming
;
Kato, Ken
;
Raymond, Eric
...
The Lancet Oncology. 24 (2023) 5 - p. 483-495 , 2023
Link:
https://doi.org/10.1016/s1470-2045(23)00108-0
RT Journal T1
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study
UL https://suche.suub.uni-bremen.de/peid=cr-10.1016_s1470-2045(23)00108-0&Exemplar=1&LAN=DE A1 Xu, Jianming A1 Kato, Ken A1 Raymond, Eric A1 Hubner, Richard A A1 Shu, Yongqian A1 Pan, Yueyin A1 Park, Sook Ryun A1 Ping, Lu A1 Jiang, Yi A1 Zhang, Jingdong A1 Wu, Xiaohong A1 Yao, Yuanhu A1 Shen, Lin A1 Kojima, Takashi A1 Gotovkin, Evgeny A1 Ishihara, Ryu A1 Wyrwicz, Lucjan A1 Van Cutsem, Eric A1 Jimenez-Fonseca, Paula A1 Lin, Chen-Yuan A1 Wang, Lei A1 Shi, Jingwen A1 Li, Liyun A1 Yoon, Harry H PB Elsevier BV YR 2023 SN 1470-2045 JF The Lancet Oncology VO 24 IS 5 SP 483 OP 495 LK http://dx.doi.org/https://doi.org/10.1016/s1470-2045(23)00108-0 DO https://doi.org/10.1016/s1470-2045(23)00108-0 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)